Electronic structural investigations of ruthenium compounds and anticancer prodrugs (Q33427427)

26 July 2017

title

Electronic structural investigations of ruthenium compounds and anticancer prodrugs (English)

1 reference

26 July 2017

Robert K Szilagyi

2

0 references

author name string

Travis V Harris

series ordinal

1

1 reference

26 July 2017

Karen L McFarlane Holman

series ordinal

3

1 reference

26 July 2017

publication date

7 April 2009

1 reference

Journal of Biological Inorganic Chemistry

26 July 2017

published in

1 reference

26 July 2017

volume

14

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

891-898

1 reference

Cis-diamminedichloroplatinum (II). A new anticancer drug

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00775-009-0501-0

Pharmacological interventions to reduce platinum-induced toxicity

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00775-009-0501-0

Density-functional approximation for the correlation energy of the inhomogeneous electron gas

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00775-009-0501-0

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

21 January 2018

1 reference

12 December 2020

A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A.

1 reference

12 December 2020

Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.

1 reference

12 December 2020

In Vivo Utilization of Oxygen and Glucose by Neoplastic Tissue

1 reference

12 December 2020

Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin.

1 reference

12 December 2020

Synthesis, Characterization and Solution Chemistry of trans-Indazoliumtetrachlorobis(Indazole)Ruthenate(III), a New Anticancer Ruthenium Complex. IR, UV, NMR, HPLC Investigations and Antitumor Activity. Crystal Structures of trans-1-Methyl-Indazoliu

1 reference

12 December 2020

Pharmacological control of lung metastases of solid tumours by a novel ruthenium complex

1 reference

12 December 2020

Computational Electrochemistry of Ruthenium Anticancer Agents. Unprecedented Benchmarking of Implicit Solvation Methods

1 reference

12 December 2020

Tuning of redox properties for the design of ruthenium anticancer drugs: part 2. Syntheses, crystal structures, and electrochemistry of potentially antitumor [Ru III/II Cl6-n(Azole)n]z(n = 3, 4, 6) complexes.

1 reference

12 December 2020

Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential

1 reference

12 December 2020

The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation

1 reference

12 December 2020

Angiogenesis: how a tumor adapts to hypoxia

1 reference

12 December 2020

Hydrolysis study of the bifunctional antitumour compound RAPTA-C, [Ru(η6-p-cymene)Cl2(pta)]

1 reference

12 December 2020

A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.

1 reference

12 December 2020

Ligand K-edge X-ray absorption spectroscopy: a direct probe of ligand-metal covalency

1 reference

12 December 2020

The binding properties of two antitumor ruthenium(III) complexes to apotransferrin

1 reference

12 December 2020

CZE-ICP-MS as a tool for studying the hydrolysis of ruthenium anticancer drug candidates and their reactivity towards the DNA model compound dGMP.

1 reference

12 December 2020

Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cells.

1 reference

12 December 2020

Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes

1 reference

12 December 2020

Efficacy of new ruthenium complexes against chemically induced autochthonous colorectal carcinoma in rats

1 reference

12 December 2020

Treatment of residual metastases with Na[trans-RuCl4 (DMSO)lm] and ruthenium uptake by tumor cells

1 reference

12 December 2020

The hydrolysis mechanism of the anticancer ruthenium drugs NAMI-A and ICR investigated by DFT-PCM calculations

1 reference

12 December 2020

Ruthenium antimetastatic agents

1 reference

12 December 2020

Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.

1 reference

12 December 2020

Chemistry. Metal-based therapeutics

1 reference

12 December 2020

Density-functional exchange-energy approximation with correct asymptotic behavior

1 reference

12 December 2020

Non-platinum chemotherapeutic metallopharmaceuticals

1 reference

12 December 2020

Kinetics and mechanism of the reduction of (ImH)[trans-RuCl4(dmso)(Im)] by ascorbic acid in acidic aqueous solution

1 reference

12 December 2020

Recent developments in the field of tumor-inhibiting metal complexes.

1 reference

12 December 2020

Antineoplastic activity of three ruthenium derivatives against chemically induced colorectal carcinoma in rats

1 reference

12 December 2020

In vitro cell cycle arrest, in vivo action on solid metastasizing tumors, and host toxicity of the antimetastatic drug NAMI-A and cisplatin.

1 reference

12 December 2020

Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A.

1 reference

12 December 2020

Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics

1 reference

12 December 2020

Probing the stability of serum protein–ruthenium(III) drug adducts in the presence of extracellular reductants using CE

1 reference

12 December 2020

A theoretical study on the hydrolysis process of the antimetastatic ruthenium(III) complex NAMI-A

1 reference

12 December 2020

10.1007/S00775-009-0501-0

Identifiers

DOI

1 reference

26 July 2017

1 reference